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It has previously been proved that sodium nitrite, infused prior to coronary artery occlusion or before 
reperfusion, results in marked antiarrhythmic effect in anaesthetized dogs. We have now examined 
whether this protection involves the modulation of gap junction (GJ) function by nitric oxide (NO), 
derived from nitrite administration under ischaemic conditions. Two groups of chloralose and urethane 
anaesthetized dogs, each containing 13 animals, were subjected to a 25 min period occlusion of the left 
anterior descending (LAD) coronary artery, followed by reperfusion. One group was infused with sodium 
nitrite (0.2 µmol/kg/min, i.v.), the other group with saline 10 min prior to reperfusion. The severities of 
arrhythmias and of ischaemia (epicardial ST-segment, total activation time), parallel with changes in 
myocardial tissue impedance, a measure of electrical coupling of gap junctions, were assessed during the 
experiments. Compared to the controls, nitrite infusion administered prior to reperfusion significantly 
attenuated the severity of ischaemia, the ischaemia-induced impedance changes and, consequently, the 
severity of arrhythmias, occurring during the 1B phase of the occlusion, and increase survival following 
reperfusion (0% vs. 85%). It is concluded that the marked antiarrhythmic effect of sodium nitrite is 
partly due, to the preservation of the electrical coupling of GJs by NO.
Keywords: Arrhythmia – sodium nitrite – gap junction – ischaemia/reperfusion – myocardial tissue 
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INTRODUCTION
We have just recently shown that inorganic sodium nitrite, administered in intrave-
nous infusion either before or during a 25 min coronary artery occlusion in anaesthe-
tized dogs, resulted in a marked protection against the ischaemia and reperfusion-
induced severe ventricular arrhythmias [14]. We have also pointed out that sodium 
nitrite was particularly effective, when it was given during the occlusion, but 10 min 
prior to reperfusion [14]. In this case, compared with the control group, in which no 
dog survived the combined ischaemia and reperfusion insult, 92% of the nitrite 
received dogs survived [14]. This marked protection was attributed to the generation 
of nitric oxide (NO) from nitrite. There is now substantial experimental and clinical 
* Corresponding author; e-mail address: vegh.agnes@med.u-szeged.hu
36 Gottfried Miskolczi et al.
Acta Biologica Hungarica 68, 2017
evidence that inorganic nitrate and nitrite, the natural oxidative metabolites of NO, 
may serve as stores of NO [9, 10, 15, 17], since they are able to rapidly reduce back 
to NO, especially under hypoxic or anoxic conditions, when a drop in pH and oxygen 
tension promotes reductive processes [30]. This enzyme-independent NO formation 
may particularly be important during ischaemia, when in the absence of oxygen, the 
generation of NO by nitric oxide synthase (NOS) becomes limited [10, 30]. Indeed, 
the infusion of nitrite, even for a short period (10 min) before reperfusion, markedly 
increased the plasma nitrate/nitrite (NOx) levels in the coronary sinus blood of the 
dogs [14]. We concluded that the antiarrhythmic effect of nitrite is associated with 
better NO availability during ischaemia, and with a subsequent NO-mediated reduc-
tion in the harmful consequences of oxidative stress [13], most probably through 
protein S-nitrosylation and/or S-glutathionylation [14]. 
There are, however, several other mechanisms, through which nitrite may influ-
ence arrhythmia generation. For example, we have shown previously that the antiar-
rhythmic effect of sodium nitroprusside can be associated with the modulator effect 
of NO on gap junctional function [6]. There is no doubt that the intercellular connec-
tions between cells, called gap junctions (GJs), play an important role in the mainte-
nance of normal impulse propagation, and that the uncoupling of GJs under ischaemic 
conditions largely contributes to arrhythmia generation, particularly during phase 1B 
[20, 21]. In contrast to the phase 1A arrhythmias, which appear soon after the occlu-
sion (between 3 and 8 min), these later occurring phase 1B arrhythmias (around 15 
min of the occlusion) are often terminated in sudden cardiac death [21]. The associa-
tion between the acute ischaemia-induced ventricular arrhythmias and GJs, as well as 
the influence of arrhythmia generation through the modification of GJs, has already 
been discussed earlier [22, 24]. 
Following this line, in the present study we have examined, whether GJs play a 
role in the marked antiarrhythmic effect of sodium nitrite, infused in dogs during 
occlusion, but just prior to reperfusion. In this experimental arrangement we have 
observed a marked protection against the phase 1B arrhythmias, and a high rate of 
survival in our previous study [14].1
MATERIALS AND METHODS
The experiments were performed on dogs of both sexes, weighing between 17 and 
25 kg (mean body weight 21 ± 2 kg). The origin and upkeep of the dogs were in 
accordance with the Hungarian law (XXVIII, chapter IV, paragraph 31) regarding the 
use of large experimental animals, which conforms to the Guide for the Care and Use 
of Laboratory Animals (ILAR, 1996), and also conformed to Directive 2010/63/EU 
of the European Parliament. The protocols were approved by the Ethical Committee 
for the Protection of Animals in Research of the University of Szeged, Szeged, 
1The arrhythmia data, obtained from 6 control and 6 sodium nitrite treated dogs, were used in this 
previous paper (kovács et al., 2015).
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Hungary (approval number: I-74-5-2012) and by the Department of Animal Health 
and Food Control of the Ministry of Agriculture and Rural Development (authority 
approval number XIII/1211/2012).
Before the experiments, the dogs were housed in an animal room (temperature 
20 °C; humidity from 40 to 70%; lighting 12 h per day; two animals per pen) for at 
least two weeks and fed a standard diet with ad libitum access to water. Food was 
withdrawn 24 h before anaesthesia. The surgical procedures were similar to those 
described previously [23]. In brief, the dogs were lightly anaesthetized with sodium 
pentobarbitone (30 mg/kg i.v.; Sigma, St. Louis, MO, USA) and the right femoral 
vein was prepared and catheterized for the administration of further anaesthetic (mix-
ture of chloralose and urethane, 60 and 200 mg kg–1, respectively; Sigma, St. Louis, 
MO, USA) to maintain anaesthesia. The left femoral vein was cannulated for the 
intravenous administration of sodium nitrite and saline. The depth of anaesthesia was 
monitored by the examination of the cornea and pain reflexes, as well as by measur-
ing the blood pressure. The animals were then intubated, and ventilated with room air 
using a Harvard respirator (Harvard Apparatus, Natick, MA, USA) at a rate and vol-
ume sufficient to maintain arterial blood gases and pH within physiological limits 
[23]. Body temperature was measured from the mid-oesophagus, and maintained by 
a heating pad at 37 ± 0.5 °C.
A polyethylene catheter was inserted into the right femoral artery to measure arte-
rial blood pressure (systolic and diastolic). A Millar tip catheter (5F, Millar 
Instruments, USA) was introduced, via the left carotid artery, into the left ventricle 
(LV) to detect changes in systolic (LVSP) and end-diastolic (LVEDP) pressures as 
well as in LVdP/dt. 
Thoracotomy was performed at the fifth intercostal space and the anterior descend-
ing branch of the left coronary artery (LAD) was prepared for occlusion just proximal 
to the first main diagonal branch. Myocardial ischaemia was induced by a 25 min 
period occlusion of the LAD, followed by rapid reperfusion. The severity of ischae-
mia was assessed by measuring changes in total activation time (TAT) and in epicar-
dial ST-segment, using a mapping electrode positioned within the ischaemic myocar-
dial region [6]. Signals were collected from 31 unipolar electrodes (inter-electrode 
distance; 2 mm) at a frequency of 1 kHz, stored on a computer and analyzed offline 
by creating activation and ST maps. Changes in epicardial activation were assessed 
as a time delay between the first and a last point activated under the electrode and 
expressed as the total activation time (TAT) in milliseconds. Elevations of epicardial 
ST-segment, recorded in each minute from the unipolar electrodes, were averaged and 
expressed in mV.
The electrical coupling of gap junctions was assessed by measuring tissue imped-
ance2 as described in detail previously [6, 19, 20]. In brief, four stainless steel elec-
trodes, mounted on a non-conductive panel, were inserted into the left ventricular 
2Since the myocardial tissue is not purely resistive (the cell membrane contains capacitance elements), 
there will be a time delay between the voltage (V measured across the tissue) and the sinusoidal current 
(I) applied through it. Therefore, myocardial impedance (Z = V/I) can be precisely defined by two com-
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wall within the proposed ischaemic myocardial area. A sub-threshold alternating 
current (10 µA, 8 kHz) was applied through the outer pair of electrodes, and voltage 
was measured between the inner electrode pair using a lock-in amplifier (SR830 DSP; 
Stanford Research Systems, CA, USA). Changes in resistivity (in Ohm.cm) and in 
phase angle (in °) were recorded by a computer with an acquisition time of 4 s and 
plotted at 1 min intervals. To eliminate small oscillations, resulting from ventilation, 
five consecutive 4 s measures were averaged at each minute.
Ventricular arrhythmias during a 25 min coronary artery occlusion and following 
reperfusion were assessed according to the Lambeth Conventions [27] with that 
modification as has been previously outlined [23]. Thus we determined the total num-
ber of ventricular premature beats (VPBs), the incidence and the number of episodes 
of ventricular tachycardia (VT), and the incidence of ventricular fibrillation (VF) 
during the occlusion period. During reperfusion, only the incidence of VF, which is a 
fatal event in this species, was determined. Dogs that were alive 5 min after reperfu-
sion were considered to be survivors. 
All parameters, together with a chest lead electrocardiogram, were measured with 
a Plugsys Haemodynamic Apparatus (Hugo Sachs Electronics, Germany) and record-
ed on a Graphtec Thermal Array Recorder (Hugo Sachs Electronics, Germany). 
Experimental protocol
A total of 26 dogs were used and randomly divided into two groups. Each animal was 
subjected to a 25 min LAD occlusion followed by rapid reperfusion. Control dogs (C; 
n = 13) were infused with saline, commencing 10 min prior to the end of the coronary 
artery occlusion. In the other group (NaNO2-PR; n = 13) sodium nitrite was adminis-
tered by intravenous infusion at a concentration of 0.2 µmol kg–1 min–1 also 10 min 
prior to reperfusion as has been described previously [14]. In dogs that survived the 
combined ischaemia and reperfusion insult, the hearts were stopped with an overdose 
of the anaesthetic either within 2 min (where myocardial tissue samples were taken) 
or 5 min (where the area at risk was determined). In dogs that suddenly fibrillated on 
reperfusion, the heart was quickly excised when the fibrillation had been observed. In 
7 control and 7 nitrite treated dogs, after excising the heart, the risk area was assessed 
by injecting Patent Blue V dye into the re-occluded artery using the same method that 
has been described in detail elsewhere [23].
ponents: tissue resistance (R) and phase angle (θ). In tissues, the impedance (Z) is a complex number 
(Z = R + jX), where R is the resistance (in phase component of V with respect to I), j is the imaginary unit 
(j = √–1), and X is the reactance (in quadrate component of V with respect to I). The time delay between 
the voltage and current waves can be determined from the phase angle [θ = arctan(X/R)] of tissue imped-
ance.
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Statistical analysis
All data are expressed as means ±S.E.M. and the differences between means were 
compared by ANOVA for repeated measures and by the one-way ANOVA as appro-
priate, using the Fisher post-hoc test. VPBs and episodes of VT were compared using 
the Kruskal–Wallis test. The incidences of arrhythmias (such as VT and VF) and 
survival from the combined ischaemia and reperfusion insult were compared by the 
Fisher’s exact test. Differences between groups were considered significant at 
P < 0.05.
RESULTS
Haemodynamic changes following a 25 min occlusion of the LAD
These are summarized in Table 1. Occlusion of the LAD resulted in marked and 
similar decreases in arterial blood pressure, left ventricular systolic pressure 
(LVSP), positive and negative dP/dtmax, and increases in LVEDP in both groups 
during the first 15 min of ischaemia. In dogs infused with sodium nitrite 10 min 
prior to reperfusion, there were no further significant alterations in the haemody-
namic parameters compared to the saline treated controls, except that the LVEDP 
significantly reduced by the end of the occlusion period. The heart rate in anaesthe-
tized dogs was practically unchanged both during occlusion and following sodium 
nitrite administration.
The severity of ventricular arrhythmias during coronary artery occlusion 
and reperfusion
The distribution and the incidence of various types of arrhythmias are illustrated in 
Figure 1. In control dogs subjected to a 25 min occlusion of the LAD, there were 
many ectopic beats (525 ± 90) and episodes of VT (19.8 ± 5.6) that occurred 92% 
←
Fig. 1. The distribution of arrhythmia events following a 25 min occlusion and reperfusion of the LAD 
in 13 control and 13 sodium nitrite-treated dogs. The filled columns represent ventricular fibrillation (VF), 
the shaded columns show periods of ventricular tachycardia (VT) and the lightly stippled columns are 
periods during which ventricular premature beats (VPBs) were evident. VF on reperfusion is shown by 
the black horizontal columns, and this was the only arrhythmia event assessed during reperfusion. In 
control dogs there were many VPBs and episodes of VT over the entire occlusion period, and in 5/13 dogs 
VF occurred during the 1B phase of the occlusion. Since, all the dogs that survived the occlusion, fibril-
lated on reperfusion, there was no survivor in this group from the combined occlusion and reperfusion 
insult. Sodium nitrite infused 10 min prior to reperfusion reduced the number of VPBs and VT episodes 
during phase 1B. In this group VF occurred in one dog during the occlusion, and in one dog following 
reperfusion, and 11 dogs out of the 13 animals survived reperfusion
42 Gottfried Miskolczi et al.
Acta Biologica Hungarica 68, 2017
Fig. 2. Distribution of VPBs and relative changes in tissue impedance (resistivity and phase angle) at one 
minute intervals over a 25 min occlusion of the LAD occlusion in control dogs and in dogs infused with 
sodium nitrite 10 min prior to reperfusion. The infusion of nitrite significantly reduced the number of 
VPBs occurring during phase 1B, and inhibited the second steep rise in tissue resistivity, as well as the 
decline in phase angle that was obvious in the controls between 15 and 25 min of the ischaemia. Values 
are means ± S.E.M. *P < 0.05 compared to the controls
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of the dogs. Furthermore, in this group 5 out of the 13 animals (38%) exhibited VF 
during occlusion and all the remaining dogs (62%) died in VF following reperfu-
sion, thus no control dog survived the combined ischaemia and reperfusion insult. 
In contrast, dogs infused with sodium nitrite 10 min prior to reperfusion showed 
significantly less VPBs and episodes, particularly during the later phase of the 
occlusion. Although in this group one dog (8%) died during the occlusion period 
and another one (8%) when the myocardium was reperfused, 85% of the animals 
infused with sodium nitrite survived the combined ischaemia and reperfusion chal-
lenge (Fig. 1).
Distribution of VPBs and changes in tissue impedance during  
a 25 min LAD occlusion 
The data are shown in Figure 2. In control dogs occlusion of the LAD resulted in an 
immediate increase in tissue resistivity and a decrease in phase angle accompanied by 
the occurrence of many ectopic beats. These changes were apparent during the first 
10 min of ischaemia (phase 1A), after which the impedance changes became slower 
and the number of VPBs significantly decreased. A second steeper rise in resistivity 
and decline in phase angle started around 13 min of the occlusion, followed immedi-
ately by the re-appearance of the phase 1B arrhythmias. In dogs that received sodium 
nitrite, the resistivity and the phase angle changes during phase 1A were similar to the 
controls, although incidentally the phase 1A arrhythmias (Figs 1, 2) were somewhat 
less pronounced in the nitrite treated than in the control animals. Nevertheless, in this 
Fig. 3. Changes in the epicardial ST-segment (A) and in the total activation time (B) during a 25 min 
occlusion of the LAD in control and nitrite infused dogs. In control animals both indices of ischaemia 
severity were markedly increased especially during the initial 5 min of the occlusion. These ischaemic 
changes were significantly reduced after the infusion of sodium nitrite. Values are means ± S.E.M. 
*P < 0.05 compared to the controls
 A B
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group, the infusion of sodium nitrite almost completely inhibited the ischaemia-
induced marked impedance changes, and significantly suppressed the ectopic activity, 
which was apparent in the controls during phase 1B. 
Changes in epicardial ST-segment and total activation time during  
LAD occlusion
We used two indices to assess the severity of ischaemia during coronary artery occlu-
sion; i.e. the changes in total activation time (TAT; Fig. 3A) and in epicardial 
ST-segment (Fig. 3B). In control dogs occlusion of the LAD resulted in immediate 
and marked increase in both parameters, reaching the maximum values within the 
first 5 min of the occlusion. The infusion of sodium nitrite 10 min prior to reperfusion 
resulted in an immediate decrease in the epicardial ST-segment and in the TAT, and 
these were significantly less pronounced by the end of the occlusion period than in 
the controls. 
Area at risk
There were no significant differences in the area at risk between the control (n = 7; 
36 ± 2%) and sodium nitrite (n = 7; 37 ± 3%) groups.
DISCUSSION
We have previously provided evidence that in dogs gap junctions play an important 
role in the generation of arrhythmias that accompany the sudden occlusion of one of 
the main branches of the left coronary artery, and that preconditioning by modifying 
the function of gap junctions may exert the protection against these severe ventricular 
arrhythmias [19, 20, 24]. We have also reported that nitric oxide (NO), which plays a 
mandatory role, both as trigger and mediator of the preconditioning-induced early 
and delayed antiarrhythmic protection [1, 11, 25, 26], attains its protective effect, 
among the others, through the modification of gap junctions [6, 22]. Since we have 
just recently published that the inorganic sodium nitrite, infused in dogs prior to and 
during the entire occlusion period, or just prior to reperfusion, results in marked anti-
arrhythmic effect [14], we have now examined whether this considerable protection 
is due, at least in part, to the regulation of gap junction function by NO, derived from 
sodium nitrite. It should be noted that the present study involves 6 control and 6 
treated dogs, of which the arrhythmia data, but not the results of the impedance meas-
urements, had already been included in a previous publication [14]. In the present 
study 7 new control and 7 sodium nitrite-treated animals were added, in order to 
precisely assess the relationship between gap junctions and the sodium nitrite-
induced antiarrhythmic effect.
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It was found that sodium nitrite, administered just that period of the occlusion 
when the phase 1B arrhythmia events are expected (i.e. around 15 min), resulted in 
immediate haemodynamic effects (e.g. a decrease in LVEDP), a reduction in ischae-
mia severity (epicardial ST-segment and total activation time), abolished the ischae-
mia-induced steep impedance changes, and simultaneously, suppressed the severe 
ventricular arrhythmias, occurring during phase 1B.
At least three conclusions can be drawn from these findings. First, the effect of 
nitrite is almost immediate, indicating a rapid conversion of nitrite to NO under 
ischaemic conditions [4, 28, 30]. We assume that by the time of the commencement 
of the infusion (i.e. 15 min of the occlusion) the ischaemic changes are sufficiently 
advanced to provide a milieu (low pH and oxygen tension) for the reduction of nitrite 
to NO. This assumption is supported by the finding that the plasma NOx levels (indi-
cator of NO formation) in the blood of the coronary sinus were markedly increased 
following nitrite infusion [14]. Since the plasma nitrate level was unchanged during 
nitrite infusion, we assume that nitrite, under these reductive conditions, most prob-
ably converted to NO [14]. 
Second, the short period of nitrite administration during ischaemia but prior to 
reperfusion can effectively increase NO bioavailability. This usually decreases fol-
lowing coronary artery occlusion, since in the absence of oxygen, the generation of 
NO from NOS activation, is reduced or even abolished [12]. Thus under such condi-
tions, replacement of NO, for example, by an enzyme-independent source, may 
reduce the ischaemic changes and the occurrence of arrhythmias during the rest of the 
ischaemia. The increased NO bioavailability, resulted from a short period of sodium 
nitrite infusion prior to reperfusion, may favourably affect the reperfusion-induced 
severe ventricular arrhythmias, such as ventricular fibrillation, which is common in 
this canine model when the coronary artery is suddenly reopened [23]. We have found 
that only one nitrite-treated dog out of the remaining 12 dogs fibrillated during reper-
fusion in contrast with the controls, in which all the dogs that survived the occlusion 
died in VF on reperfusion. These findings are in accordance with the results of 
Gonzalez et al. [5], who showed also in dogs that infusion of nitrite during the last 
5 min of ischaemia, significantly reduce the infarct size and improve the recovery of 
contractile function after reperfusion. One of the mechanisms, which may play a role 
in the protection against the reperfusion-induced injury, is the suppression of the 
generation of oxidative stress products. There is substantial evidence that NO can 
regulate the production of reactive oxygen species (ROS) during ischaemia and rep-
erfusion [3, 7, 12]. For example, we have shown previously that the increase of NO 
bioavailability during ischaemia by either preconditioning or the administration of an 
NO donors, suppresses the reperfusion-induced ROS generation and the arrhythmias 
[12]. Similarly, we have found that sodium nitrite, regardless of the duration of infu-
sion, significantly suppressed the superoxide and peroxynitrite production during 
reperfusion [14].
Third, the results of the present study confirm our hypothesis that NO, among its 
several other effects as discussed in detail elsewhere [e.g. 12, 14, 24], may influence 
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cardiac gap junctions and thereby modify the generation of the ischaemia and reper-
fusion-induced severe ventricular arrhythmias [6, 22]. The effect of NO derived from 
sodium nitrite on gap junction channels is also immediate, since after the commence-
ment of the infusion the second steep rise in resistivity and decline in phase angle 
were absent (the changes of these parameters after 15 min of ischaemia remained 
virtually constant), and the ectopic activity during phase 1B was considerable sup-
pressed. This finding suggests that the infusion of sodium nitrite, just at a time of the 
occlusion period, when the serious, often life-threatening phase 1B arrhythmias start 
to appear, is able to inhibit the generation of these arrhythmias, and this effect can be 
associated with the preservation of gap junctions by NO. Although it is still not 
known whether opening or closing of gap junctions by NO leads to the antiarrhythmic 
protection, our electrical impedance measurements suggest that sodium nitrite inhib-
its the further uncoupling of gap junctions, since it abolished those steep impedance 
changes that had preceded the occurrence of the phase 1B arrhythmias. Although we 
are aware that the measurement of impedance changes only provide indirect evidence 
for the opened/closed status of gap junctions, since a substantial portion of gap junc-
tions needs to be closed to detect changes in tissue resistivity [8], we assume that NO, 
derived from sodium nitrite, keeps open, rather than close gap junction channels. The 
assessment of the phosphorylation of connexin 43 (Cx43), the main structural protein 
of gap junctions, would provide further information about the open/closed status of 
these channels. There is a consensus that the phosphorylated form of Cx43 can be 
associated with the open form of the channel, whereas a dephosphorylated form indi-
cates the closure of gap junctions [2]. In the present study we did not determine con-
nexin phosphorylation, since we know that the ischaemia-induced dephosphorylation 
of this protein rapidly recovers following reperfusion, but we have previous evidence 
that NO, released, for example, from sodium nitroprusside, keeps Cx43 in phospho-
rylated form and the gap junctions in opened state during ischaemia [6].
The other consequence of the rapid release of NO from sodium nitrite during 
ischaemia is the marked protection against the reperfusion-induced severe ventricular 
arrhythmias. The reduction in VF during reperfusion is particularly pronounced, 
resulting in a high rate of survival (85%) in the nitrite treated group. As to whether 
this marked protection against the reperfusion-induced VF is associated with a direct 
effect of NO on gap junctions occurring during reperfusion we do not know, since it 
is difficult to measure the impedance changes soon after reperfusion, when VF com-
monly occurred particularly in control dogs. However, it is more than likely that the 
outcome of reperfusion, and thus the severity of reperfusion-induced arrhythmias, 
largely depends on the severity of the antecedent ischaemia, we assume that the 
nitrite-induced less severe ischaemic changes and the suppression of arrhythmias dur-
ing phase 1B, via the modulation of gap junctions, may contribute to the better sur-
vival of these animals from the combined ischaemia and reperfusion insult. Gonzalez 
et al. [5] proposed that administration of nitrite just prior to reperfusion might have a 
particular clinical value, as adjunctive pharmacological therapy to coronary angio-
plasty interventions, by improving myocardial salvage, and consequently, by provid-
ing a better cardiac function following reperfusion of an acute myocardial ischaemic 
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insult [5]. We have now confirmed these findings and provided further evidence that 
nitrite by modulating gap junctions may protect the heart against the ischaemia and 
reperfusion-induced severe, life-threatening ventricular arrhythmias.
In conclusion, the present study provides evidence that NO, deriving from mole-
cules which readily release NO, protects the heart against the acute ischaemia and 
reperfusion-induced severe, often fatal rhythm disturbances. Although other effects, 
such as the preservation of endothelial function [16] or the favourable haemody-
namic (e.g. the reduction in preload [LVEDP], and consequently in myocardial 
stretch) and anti-aggregator abilities of NO donors, cannot be excluded, as indirect 
factors, from the antiarrhythmic effect of sodium nitrite, the prompt inhibition of the 
impedance changes and, almost in parallel, the suppression of the phase 1B arrhyth-
mias that occur immediately after the administration of sodium nitrite, suggest a 
direct modulator effect of NO on gap junctions. As to whether this involves the 
NO-induced increase in myocardial cGMP and a resultant decrease in the intracellular 
calcium level [18], which directly modulates gap junctions during ischaemia [29], or 
whether nitrite, through protein S-nitrosylation (e.g. S-nitrosylation of connexin43) 
result in modification in gap junction structure and/or function, warrants further 
investigations.
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